» Articles » PMID: 2386739

The Use of Vascularised Spheroids to Investigate the Action of Flavone Acetic Acid on Tumour Blood Vessels

Overview
Journal Br J Cancer
Specialty Oncology
Date 1990 Aug 1
PMID 2386739
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

EMT6 multicellular spheroids were introduced into the peritoneal cavities of mice and allowed to become vascularised, resulting in solid spherical tumours. The necrotic cores of the initially avascular spheroids were replaced by vascularised tumour tissue but the outer zones of the spheroids failed to become vascularised. The presence of both vascular and avascular components in each spheroid allowed the role of the vasculature in the antitumour action of flavone acetic acid (FAA) to be determined. Eighteen hours after treatment with FAA 0.8 mmol kg-1, the vascularised core became necrotic and haemorrhagic, while the outer avascular zone remained viable. Tumour cells which were infiltrating superficial sub-mesothelial fat did not become necrotic despite the presence of numerous thrombi in associated vessels. Injection of two fluorescent vascular markers, the first (Hoechst 33342) together with FAA, and the second (10-nonyl acridine orange) 4 h later, demonstrated that there is a marked loss of blood flow in the spheroids. These results provide further evidence that FAA kills blood vessel-dependent tumour cells by interrupting the tumour blood supply.

Citing Articles

Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells.

Panaro N, Popescu N, Harris S, Thorgeirsson U Br J Cancer. 1999; 80(12):1905-11.

PMID: 10471038 PMC: 2363136. DOI: 10.1038/sj.bjc.6690619.


Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.

Lash C, Li A, Rutland M, Baguley B, Zwi L, Wilson W Br J Cancer. 1998; 78(4):439-45.

PMID: 9716024 PMC: 2063102. DOI: 10.1038/bjc.1998.512.


Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours.

Ching L, Joseph W, Zhuang L, Baguley B Cancer Chemother Pharmacol. 1994; 35(2):153-60.

PMID: 7987993 DOI: 10.1007/BF00686639.


Tumour vasculature--a potential therapeutic target.

Baillie C, Winslet M, BRADLEY N Br J Cancer. 1995; 72(2):257-67.

PMID: 7543770 PMC: 2034004. DOI: 10.1038/bjc.1995.323.


Vascular attack as a therapeutic strategy for cancer.

Denekamp J Cancer Metastasis Rev. 1990; 9(3):267-82.

PMID: 2292139 DOI: 10.1007/BF00046365.


References
1.
Smith G, Calveley S, Smith M, Baguley B . Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. Eur J Cancer Clin Oncol. 1987; 23(8):1209-11. DOI: 10.1016/0277-5379(87)90157-x. View

2.
Folkman J . Tumor angiogenesis. Adv Cancer Res. 1985; 43:175-203. DOI: 10.1016/s0065-230x(08)60946-x. View

3.
Dusseau J, Hutchins P . Hypoxia-induced angiogenesis in chick chorioallantoic membranes: a role for adenosine. Respir Physiol. 1988; 71(1):33-44. DOI: 10.1016/0034-5687(88)90113-2. View

4.
Watanabe N, Niitsu Y, Umeno H, Kuriyama H, Neda H, Yamauchi N . Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 1988; 48(8):2179-83. View

5.
NORTH R, Havell E . The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma. J Exp Med. 1988; 167(3):1086-99. PMC: 2188903. DOI: 10.1084/jem.167.3.1086. View